Zydus Lifesciences informs about press release

16 Nov 2022 Evaluate
Zydus Lifesciences has informed that it enclosed press release titled ‘Zydus Lifesciences gets exclusive marketing rights for Can Assist Breast- an innovative prognostic test for breast cancer patients’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

879.40 -26.60 (-2.94%)
16-Mar-2026 13:22 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1774.20
Dr. Reddys Lab 1270.20
Cipla 1298.00
Zydus Lifesciences 879.40
Lupin 2291.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×